Sulayman SRL
Sulayman reported total assets of 59,800 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026).
The score of Sulayman shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sulayman's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
Sulayman's financial analysis
- Solvency78.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sulayman
Sulayman's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1001.603.687
- VAT number
- BE1001603687
- Peppol
- Registered · 0208:1001603687 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Oct 2023
- Registered office
- 7850 Enghien
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sulayman (SRL) has been based in Enghien since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 20,907 € and equity of 47,068 €; its revenue is not published. Its solvency stands at 78.7%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sulayman
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie MORY Retail sale of pharmaceutical products Saint-Gilles · balance sheet 349,639 €
- Katrien Smets Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 56,328 €
- Alchemiste Retail sale of pharmaceutical products Aalter · balance sheet 73,555 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- T.R.F. pharma Retail sale of pharmaceutical products Fléron · balance sheet 70,151 €
- Dynaderm Retail sale of pharmaceutical products Wavre · balance sheet 47,613 €
- Kolibrie Veterinair Distributiecentrum Wholesale of pharmaceutical and medical goods Beringen · balance sheet 56,858 €
- Marc-Pharma Retail sale of pharmaceutical products Walcourt · balance sheet 36,076 €
Frequently asked questions about Sulayman
What is the revenue of Sulayman?
Sulayman files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sulayman?
In Belgium, the VAT number is the company number prefixed with BE: BE1001603687 for Sulayman, if the company is VAT-registered. Its company number (CBE) is 1001.603.687.
Where is the registered office of Sulayman?
According to the CBE register, the registered office of Sulayman is in 7850 Enghien.
What is the equity of Sulayman?
At the close of the 2025 financial year, the equity of Sulayman amounts to 47,068 €, a solvency of 78.7% of total assets.
Who manages Sulayman?
The register lists 1 active mandates at Sulayman. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sulayman
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →